Macleods Pharmaceuticals Limited

Form 483 issued May 26, 2023 · Daman, India

Inspection
May 22 – May 26, 2023
Investigator
Teresa I. Navas
Observations
1
Pages
2
FEI number
3006363714

In short: On May 26, 2023, FDA issued a Form 483 with 1 observation to Macleods Pharmaceuticals Limited in Daman, Daman (FEI 3006363714) after an inspection that ran May 22 – May 26, 2023. The investigator was Teresa I. Navas. Most observations concern facilities & equipment; the most-cited regulation is 21 CFR 211.63 (equipment design, size, and location).

At a glance

1 of 1 observations on this 483 concern facilities & equipment.

Facilities & equipment1

Most cited: 21 CFR 211.63 (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Macleods Pharmaceuticals Limited?

FDA listed 1 observation on this Form 483, mostly about facilities & equipment. The most-cited regulation is 21 CFR 211.63 (equipment design, size, and location). The opening words of each observation are shown on this page.

Who inspected Macleods Pharmaceuticals Limited?

Teresa I. Navas is named on this Form 483, for the inspection of May 22 – May 26, 2023. Each investigator has a profile showing what they cite most.

When was Macleods Pharmaceuticals Limited inspected by FDA?

The inspection ran May 22 – May 26, 2023, and the Form 483 is dated May 26, 2023.

How do I get the full Form 483 for Macleods Pharmaceuticals Limited?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free